Elena Baldissera Selected Research

Microvascular Angina (Cardiac Syndrome X)

2/2018

Prevalence of Takayasu arteritis in young women with acute ischemic heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Baldissera Research Topics

Disease

12	Takayasu Arteritis (Arteritis, Takayasu's) 10/2023 - 10/2011
7	Inflammation (Inflammations) 12/2020 - 01/2009
6	Adult-Onset Still's Disease 01/2020 - 08/2010
4	Rheumatoid Arthritis 01/2020 - 06/2006
2	Vasculitis (Vasculitides) 01/2023 - 08/2015
2	Arteritis 01/2017 - 11/2014
2	Arthritis (Polyarthritis) 09/2015 - 08/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024
1	Neoplasms (Cancer) 03/2024
1	Giant Cell Arteritis (Horton Disease) 01/2023
1	COVID-19 01/2020
1	Mycoses (Diseases, Fungus) 01/2020
1	Immunoglobulin G4-Related Disease 01/2020
1	Exanthema (Rash) 01/2019
1	Atherosclerosis 02/2018
1	Cardiomyopathies (Cardiomyopathy) 02/2018
1	Microvascular Angina (Cardiac Syndrome X) 02/2018
1	Hypertension (High Blood Pressure) 01/2016
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2015
1	Microscopic Polyangiitis 08/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2015
1	Systemic Scleroderma (Systemic Sclerosis) 03/2014
1	Fibrosis (Cirrhosis) 03/2014
1	Pulmonary Hypertension 03/2014
1	Sclerosis 03/2014
1	Amenorrhea 12/2013
1	Stable Angina 01/2012
1	Bone Fractures (Bone Fracture) 01/2012
1	Myocardial Infarction 01/2012
1	Acute Coronary Syndrome 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Systemic Vasculitis 01/2012
1	Sepsis (Septicemia) 01/2012
1	Latent Tuberculosis 10/2010
1	Tuberculosis (Tuberculoses) 10/2010

Drug/Important Bio-Agent (IBA)

5	tocilizumab (atlizumab)FDA Link 01/2023 - 12/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 06/2006
3	Interleukin-1 (Interleukin 1)IBA 12/2020 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 12/2020 - 08/2015
3	C-Reactive ProteinIBA 01/2017 - 10/2011
2	Monoclonal AntibodiesIBA 03/2024 - 01/2020
2	Rituximab (Mabthera)FDA Link 10/2023 - 01/2020
2	SteroidsIBA 01/2023 - 08/2010
2	Infliximab (Remicade)FDA Link 02/2022 - 01/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2019
2	canakinumab FDA Link 02/2019 - 01/2019
2	Chromogranin AIBA 01/2016 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 11/2014 - 10/2011
1	secukinumabIBA 03/2024
1	Interleukin-17 (Interleukin 17)IBA 03/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	SuspensionsIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	Biosimilar PharmaceuticalsIBA 01/2021
1	EpitopesIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Sympathomimetics (Sympathomimetic Amines)IBA 02/2018
1	InterleukinsIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2016
1	Proton Pump InhibitorsIBA 01/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2015
1	Contrast MediaIBA 11/2014
1	Pattern Recognition ReceptorsIBA 11/2014
1	ProcalcitoninIBA 07/2014
1	IntegrinsIBA 03/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	HMGB1 Protein (HMG1)IBA 03/2014
1	CytokinesIBA 02/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	gadofosveset trisodium (MS 325)FDA Link 03/2012
1	Peroxidase (Myeloperoxidase)IBA 01/2012
1	P-SelectinIBA 01/2012
1	Tuberculin (PPD)IBA 10/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2010

Therapy/Procedure

4	Therapeutics 01/2023 - 08/2010
1	Duration of Therapy 01/2020
1	Remission Induction 01/2020